A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

PURPOSE: We evaluated the safety and efficacy of biweekly capecitabine in combination with oxaliplatin in previously untreated patients with locally advanced or metastatic gastric cancer. METHODS: Patients received oral capecitabine 1,000 mg/m(2) twice daily on days 1–10 plus oxaliplatin 85 mg/m(2)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chao, Yee, Hsieh, Jan-Sing, Yeh, Hsien-Tang, Su, Yu-Chieh, Wu, Cheng-Chung, Chen, Jen-Shi, Tai, Cheng-Jeng, Bai, Li-Yuan, Yeh, Kun-Huei, Su, Wu-Chou, Li, Chung-Pin
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3965832/
https://ncbi.nlm.nih.gov/pubmed/24531611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2407-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares